Evidence map›Paper›PMID 33919882›Full record

ReviewJournal of personalized medicine2021

Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape.

Avishek Chatterjee, Cosimo Nardi, Cary Oberije, Philippe Lambin

Open access · goldAbstract readReview
In one paragraph

Review in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Avishek ChatterjeeThe D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0003-3536-670X
Cosimo NardiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-5489-7824
Cary OberijeThe D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 ER Maastricht, The Netherlands.
Philippe LambinThe D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0001-7961-0191
Maastricht University · NLUniversity of Florence · IT

Funding

Horizon 2020 101016131Innovative Medicines Initiative 101005122
6 · The paper itself

Abstract

backgroundSearching through the COVID-19 research literature to gain actionable clinical insight is a formidable task, even for experts. The usefulness of this corpus in terms of improving patient care is tied to the ability to see the big picture that emerges when the studies are seen in conjunction rather than in isolation. When the answer to a search query requires linking together multiple pieces of information across documents, simple keyword searches are insufficient. To answer such complex information needs, an innovative artificial intelligence (AI) technology named a knowledge graph (KG) could prove to be effective.

methodsWe conducted an exploratory literature review of KG applications in the context of COVID-19. The search term used was "covid-19 knowledge graph". In addition to PubMed, the first five pages of search results for Google Scholar and Google were considered for inclusion. Google Scholar was used to include non-peer-reviewed or non-indexed articles such as pre-prints and conference proceedings. Google was used to identify companies or consortiums active in this domain that have not published any literature, peer-reviewed or otherwise.

resultsOur search yielded 34 results on PubMed and 50 results each on Google and Google Scholar. We found KGs being used for facilitating literature search, drug repurposing, clinical trial mapping, and risk factor analysis.

conclusionsOur synopses of these works make a compelling case for the utility of this nascent field of research.

Indexed as

COVID-19drug repurposingknowledge graphnatural language processing

Identifiers

PMID33919882
PMCPMC8070774
OpenAlexW3156378390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.